Xerosis and pityriasis alba-like changes associated with zonisamide
نویسندگان
چکیده
منابع مشابه
Pityriasis alba with poliosis.
Pityriasis alba is a skin disease, commonly seen in children and young adults. This case presents the ocular association of this disease in a 10 years old Pakistani male. Ocular features in this case were poliosis, tilted disc, high myopia and chorioretinal degeneration. Tilted discs and high myopia can be coincidental but poliosis and decreased pigment in retinal pigment epithelium are closely...
متن کاملOn atopic and idiopathic extensive pityriasis alba.
Letters must be signed by all authors, typewritten double spaced, and must not exceed two pages of text including references. Two copies of all letters should be submitted along with one copy on disk. Letters should not duplicate material submitted or published in other journals. Prepublication proofs will not be provided. To the Editor: We read with interest the description of extensive pityri...
متن کاملA Case of Extensive Pityriasis Alba.
Pityriasis alba (PA) is a common benign disease, characterized by hypopigmented macules or patches on the face, usually seen in children. However, two uncommon variants exist, a pigmenting type and an extensive type. Extensive PA is rare. The lesions tend to be less scaly, more persistent, more generalized, more symmetrical, and more frequently seen over the trunk and less so over the face. We ...
متن کاملPityriasis Alba: A Condition with Possibly Multiple Etiologies
Pityriasis alba is a common hypomelanosis which is generally seen in young children. There is no specific known cause for this condition; however, studies to elucidate pathogenic factors seem to suggest that there are at least five separate causes for the condition. This list includes dermatitis, photosensitivity, fungal and bacterial pathogenesis, and post-inflammatory alterations. An evaluati...
متن کاملIbrutinib-associated pityriasis rosea–like rash
CLL: chronic lymphocytic leukemia PR: pityriasis rosea EGFR: epidermal growth factor receptor PDGFR: platelet-derived growth factor receptor I brutinib, a Bruton tyrosine kinase inhibitor, is a new oral agent approved for the treatment of chronic lymphocytic leukemia (CLL). Ibrutinib is well-tolerated, with the majority of its adverse events within grade 1 or 2 severity. The most common nonhema...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Dermatology, Venereology and Leprology
سال: 2008
ISSN: 0378-6323
DOI: 10.4103/0378-6323.39714